Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Targeted Molecular Diagnostics has announced the availability of the PhosphoGuard kit for the preservation of phosphoproteins during tissue fixation and processing.
Subscribe to our email newsletter
Targeted Molecular Diagnostics (TMD) has formulated a proprietary solution of broad-spectrum phosphatase inhibitors in the PhosphoGuard kit which has been used in several Phase II and III oncology clinical trials for targeted therapies such as Tykerb. PhosphoGuard is available in a 10-test research use format or as a comprehensive single use kit designed for use in clinical trials.
Phosphorylated proteins are useful markers that may be essential in predicting patient response or resistance to targeted cancer therapies.